Pangaea Biotech SL:企業の製品パイプライン分析2018

◆英語タイトル:Pangaea Biotech SL - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C2784
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥202,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥303,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pangaea Biotech SL (Pangaea) is a provider of molecular diagnostics and research and development services for cancer treatment. The company discovers and develops gene signatures and prognostic markers. Its services include molecular diagnosis, in vitro drug testing, clinical trials, biomarker discovery, drug development, dx platform validation, in licensing and out licensing services. Pangaea’s molecular diagnosis services comprise gene amplification and translocation testing; mutation analysis in tumor tissue and blood, immuno-histochemistry and gene expression programs. The company improves clinical development process through discovery of novel markers and validation in tumor samples and cell lines. It operates through pharmaceutical, diagnostics and biotech companies for anti-cancer drug development. Pangaea is headquartered in Barcelona, Spain.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Pangaea Biotech SL
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Pangaea Biotech SL Company Overview 4
Pangaea Biotech SL Company Snapshot 4
Pangaea Biotech SL Pipeline Products and Ongoing Clinical Trials Overview 4
Pangaea Biotech SL – Pipeline Analysis Overview 6
Pangaea Biotech SL – Key Facts 6
Pangaea Biotech SL – Major Products and Services 7
Pangaea Biotech SL Pipeline Products by Development Stage 8
Pangaea Biotech SL Pipeline Products Overview 10
BRCA1 RNA Test 10
BRCA1 RNA Test Product Overview 10
EGFR Enrichment Test 11
EGFR Enrichment Test Product Overview 11
EGFR Serum Mutation Test 12
EGFR Serum Mutation Test Product Overview 12
Genetic Mutation Test – Breast Cancer 13
Genetic Mutation Test – Breast Cancer Product Overview 13
Genetic Mutation Test – Colon Cancer 14
Genetic Mutation Test – Colon Cancer Product Overview 14
Genetic Mutation Test – Melanoma 15
Genetic Mutation Test – Melanoma Product Overview 15
Genetic Mutation Test – Pancreatic Cancer 16
Genetic Mutation Test – Pancreatic Cancer Product Overview 16
Pangaea Biotech SL – Key Competitors 17
Pangaea Biotech SL – Key Employees 18
Pangaea Biotech SL – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Pangaea Biotech SL, Recent Developments 20
Feb 02, 2015: LABCO and PANGAEA, led by Dr Rafael Rosell, join forces to launch a non-invasive test for monitoring cancer treatment 20
Appendix 21
Methodology 21
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Pangaea Biotech SL Pipeline Products and Ongoing Clinical Trials Overview 4
Pangaea Biotech SL Pipeline Products by Equipment Type 5
Pangaea Biotech SL Pipeline Products by Indication 5
Pangaea Biotech SL, Key Facts 6
Pangaea Biotech SL, Major Products and Services 7
Pangaea Biotech SL Number of Pipeline Products by Development Stage 8
Pangaea Biotech SL Pipeline Products Summary by Development Stage 9
BRCA1 RNA Test - Product Status 10
BRCA1 RNA Test - Product Description 10
EGFR Enrichment Test - Product Status 11
EGFR Enrichment Test - Product Description 11
EGFR Serum Mutation Test - Product Status 12
EGFR Serum Mutation Test - Product Description 12
Genetic Mutation Test - Breast Cancer - Product Status 13
Genetic Mutation Test - Breast Cancer - Product Description 13
Genetic Mutation Test - Colon Cancer - Product Status 14
Genetic Mutation Test - Colon Cancer - Product Description 14
Genetic Mutation Test - Melanoma - Product Status 15
Genetic Mutation Test - Melanoma - Product Description 15
Genetic Mutation Test - Pancreatic Cancer - Product Status 16
Genetic Mutation Test - Pancreatic Cancer - Product Description 16
Pangaea Biotech SL, Key Employees 18
Glossary 23

List of Figures
Pangaea Biotech SL Pipeline Products by Equipment Type 5
Pangaea Biotech SL Pipeline Products by Development Stage 8

★海外企業調査レポート[Pangaea Biotech SL:企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Antero Resources Corp (AR):企業の財務・戦略的SWOT分析
    Antero Resources Corp (AR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Time Inc.:企業のM&A・事業提携・投資動向
    Time Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Time Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Univalor-製薬・医療分野:企業M&A・提携分析
    Summary Univalor is a university technology transfer organization which optimizes research outcomes by commercializing the technological innovations of researchers from academic institutions and health centers. The organization offers researcher services such as evaluating the technical feasibility …
  • Moneygram International, Inc.:企業のM&A・事業提携・投資動向
    Moneygram International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moneygram International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Concord Medical Services Holdings Ltd (CCM):製薬・医療:M&Aディール及び事業提携情報
    Summary Concord Medical Services Holdings Ltd (CMS) is a diagnostic imaging center that offers clinical support services and laboratory services. The center offers radiotherapy and diagnostic imaging equipment services such as head gamma knife systems, body gamma knife systems and linear accelerator …
  • Sutter Health-製薬・医療分野:企業M&A・提携分析
    Summary Sutter Health (Sutter Health) is a non-profit healthcare service provider, which provides health care service through its hospitals, ambulatory surgery centers, cardiac centers, cancer centers, rehabilitation centers and others. It serves communities across Northern California- in the San Fr …
  • RTL Group S.A. (RTL):企業の財務・戦略的SWOT分析
    RTL Group S.A. (RTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Carl Zeiss Meditec AG (AFX):製品パイプライン分析
    Summary Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, an integrated medical technology company which operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. It provides comprehensive packages of solutions for the diagnosis and treatment of ey …
  • China Digital Culture (Group) Limited (8175):企業の財務・戦略的SWOT分析
    China Digital Culture (Group) Limited (8175) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Aluar Aluminio Argentino SAIC:企業の戦略・SWOT・財務分析
    Aluar Aluminio Argentino SAIC - Strategy, SWOT and Corporate Finance Report Summary Aluar Aluminio Argentino SAIC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Trinity Industries Inc (TRN):企業の財務・戦略的SWOT分析
    Trinity Industries Inc (TRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Essar Power Limited-エネルギー分野:企業M&A・提携分析
    Summary Essar Power Limited (Essar Power), a subsidiary of Essar Energy Limited, is a power utility which produces electricity and thermal energy. It generates power from coal, natural gas, and co-generation plants. The company owns and operates power generation plants in India and Canada. Through i …
  • Protagen AG:医療機器:M&Aディール及び事業提携情報
    Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa SSC, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyeliti …
  • Okinawa Electric Power Company Incorporated (9511):企業の財務・戦略的SWOT分析
    Okinawa Electric Power Company Incorporated (9511) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Reinsurance Group of America Inc:企業の戦略・SWOT・財務分析
    Reinsurance Group of America Inc - Strategy, SWOT and Corporate Finance Report Summary Reinsurance Group of America Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Cellnovo Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cellnovo Ltd (Cellnovo), formerly Starbridge Systems Ltd is a provider of conventional diabetes care technology solutions. The company offers mobile diabetes management systems such as insulin patch pump, cellular-enabled wireless touchscreen handset with integrated blood glucose meter, acti …
  • Stereotaxis Inc (STXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Stereotaxis Inc (Stereotaxis) designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch solution is an advanced remote robotic navigation system for use in interventional lab for the treatm …
  • Sigla, S.A.:企業の戦略的SWOT分析
    Sigla, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SciClone Pharmaceuticals Inc (SCLN)-製薬・医療分野:企業M&A・提携分析
    Summary SciClone Pharmaceuticals Inc (SciClone) develops and commercializes products for the treatment of cancer, cardiovascular disorders and infectious diseases. The company’s lead product, Zadaxin (thymalfasin), an immunostimulatory agent approved for the treatment of hepatitis B virus (HBV), hep …
  • Cocoon Holdings Ltd (428):企業の財務・戦略的SWOT分析
    Cocoon Holdings Ltd (428) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆